Literature DB >> 15175273

Variation in USF1 shows haplotype effects, gene : gene and gene : environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II.

Wendy Putt1, Jutta Palmen, Viviane Nicaud, David-Alexandre Tregouet, Nadia Tahri-Daizadeh, David M Flavell, Steve E Humphries, Philippa J Talmud.   

Abstract

Upstream stimulatory factor 1 (USF 1), is a transcription factor controlling expression of several genes involved in lipid and glucose homeostasis and co-localizes with familial combined hyperlipidemia (FCHL) and type 2 diabetes on chromosome 1q22-23. We sequenced USF1 in 24 UK FCHL probands, but found no rare or common cSNPs. Three common intronic single nucleotide ploymorphisms (SNP), 306A>G, 475C>T and 1748C>T, were identified and their association was examined with fasting and postprandial lipids and after an oral glucose tolerance test (OGTT) in the European Atherosclerosis Research Study II offspring study. There were no significant differences in allelic frequencies of the SNPs between cases and controls. Individually none of the SNPs showed significant associations with any parameter. In haplotype analysis, compared with other haplotypes, 475C/1748T showed significantly higher and 475T/1748T showed lower peak glucose (P=0.004 and 0.07, respectively) during the OGTT. There was significant case-control heterogeneity in the interaction of genotype with body mass index, on fasting low density lipoprotein with 306A>G and 1748C>T, and on borderline significance with fasting glucose with 475C>T (P=0.002, 0.0007 and 0.015, respectively). Furthermore, 475C>T showed interaction with both HSL-60C>G (case-control heterogeneity P=0.0002) on AUC TG and APOC3 -482C>T on plasma apoE levels (P=0.0012). Thus, in these healthy young men, variation in USF1 was the influencing feature of both glucose and lipid homeostasis showing case-control heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15175273     DOI: 10.1093/hmg/ddh168

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  23 in total

1.  Two polymorphisms of USF1 gene (-202G>A and -844C>T) may be associated with hepatocellular carcinoma susceptibility based on a case-control study in Chinese Han population.

Authors:  Xu Zhou; Hua-qiang Zhu; Chao-qun Ma; Hong-guang Li; Fang-feng Liu; Hong Chang; Jun Lu
Journal:  Med Oncol       Date:  2014-11-01       Impact factor: 3.064

2.  Upstream transcription factor 1 gene polymorphisms are associated with high antilipolytic insulin sensitivity and show gene-gene interactions.

Authors:  Konstantinos Kantartzis; Andreas Fritsche; Fausto Machicao; Michael Stumvoll; Jürgen Machann; Fritz Schick; Hans-Ulrich Häring; Norbert Stefan
Journal:  J Mol Med (Berl)       Date:  2006-09-26       Impact factor: 4.599

3.  The linkage and association of the gene encoding upstream stimulatory factor 1 with type 2 diabetes and metabolic syndrome in the Chinese population.

Authors:  M C Y Ng; K Miyake; W Y So; E W M Poon; V K L Lam; J K Y Li; N J Cox; G I Bell; J C N Chan
Journal:  Diabetologia       Date:  2005-08-26       Impact factor: 10.122

4.  Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides.

Authors:  Hilary Coon; Yuanpei Xin; Paul N Hopkins; Richard M Cawthon; Sandra J Hasstedt; Steven C Hunt
Journal:  Hum Genet       Date:  2005-06-16       Impact factor: 4.132

5.  Significant association between upstream transcription factor 1 rs2516839 polymorphism and hepatocellular carcinoma risk: a case-control study.

Authors:  Xiaodong Zhao; Tianyi Wang; Bo Liu; Zhenzhou Wu; Shuo Yu; Tao Wang
Journal:  Tumour Biol       Date:  2014-12-06

6.  Gene-gene interaction between APOA5 and USF1: two candidate genes for the metabolic syndrome.

Authors:  Paula Singmann; Jens Baumert; Christian Herder; Christa Meisinger; Christina Holzapfel; Norman Klopp; H-Erich Wichmann; Martin Klingenspor; Wolfgang Rathmann; Thomas Illig; Harald Grallert
Journal:  Obes Facts       Date:  2009-07-20       Impact factor: 3.942

7.  On the use of variance per genotype as a tool to identify quantitative trait interaction effects: a report from the Women's Genome Health Study.

Authors:  Guillaume Paré; Nancy R Cook; Paul M Ridker; Daniel I Chasman
Journal:  PLoS Genet       Date:  2010-06-17       Impact factor: 5.917

8.  A systems genetics approach implicates USF1, FADS3, and other causal candidate genes for familial combined hyperlipidemia.

Authors:  Christopher L Plaisier; Steve Horvath; Adriana Huertas-Vazquez; Ivette Cruz-Bautista; Miguel F Herrera; Teresa Tusie-Luna; Carlos Aguilar-Salinas; Päivi Pajukanta
Journal:  PLoS Genet       Date:  2009-09-11       Impact factor: 5.917

9.  Association analysis of allelic variants of USF1 in coronary atherosclerosis.

Authors:  Kati Kristiansson; Erkki Ilveskoski; Terho Lehtimäki; Leena Peltonen; Markus Perola; Pekka J Karhunen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-14       Impact factor: 8.311

10.  USF1 gene variants contribute to metabolic traits in men in a longitudinal 32-year follow-up study.

Authors:  K Auro; K Kristiansson; B Zethelius; C Berne; L Lannfelt; M-R Taskinen; M Jauhiainen; M Perola; L Peltonen; A-C Syvänen
Journal:  Diabetologia       Date:  2007-12-21       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.